Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 5.2B | 5.4B | 6.1B | 5.5B |
| Cost of revenue | 4.2B | 4.6B | 4.0B | 4.1B |
| Gross profit | 956M | 814M | 2.1B | 1.5B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 457M | 422M | 446M | 414M |
| Other operating expenses | 607M | 646M | 642M | 572M |
| Operating income | -108M | -254M | 1.0B | 466M |
| Non operating interest income | ||||
| Income | 75M | 95M | 114M | 97M |
| Expense | 165M | 176M | 171M | 174M |
| Other income expense | 31M | -386M | -86M | 15M |
| Pretax income | -167M | -721M | 897M | 404M |
| Tax provision | -65M | -77M | -1.1B | -6M |
| Net income | -102M | -644M | 2.0B | 410M |
| Basic EPS | -0.3 | — | 5.7 | 1.1 |
| Diluted EPS | -0.4 | — | 5.4 | 1.0 |
| Basic average shares | 330M | — | 358M | 358M |
| Diluted average shares | 348M | — | 376M | 376M |
| EBITDA | 450M | 287M | 1.6B | 999M |
| Net income from continuing op. | -102M | -644M | 2.0B | 410M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |